Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 11 citing articles:

Targeting protein-protein interaction interfaces with antiviral N protein inhibitor in SARS-CoV-2
Jhen-Yi Hong, Shih‐Chao Lin, Kylene Kehn‐Hall, et al.
Biophysical Journal (2024) Vol. 123, Iss. 4, pp. 478-488
Closed Access | Times Cited: 5
Targeting protein-protein interactions with low molecular weight and short peptide modulators: insights on disease pathways and starting points for drug discovery
Daniela Trisciuzzi, Bruno O. Villoutreix, Lydia Siragusa, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 7, pp. 737-752
Closed Access | Times Cited: 12
Broad-Spectrum Small-Molecule Inhibitors of the SARS-CoV-2 Spike—ACE2 Protein–Protein Interaction from a Chemical Space of Privileged Protein Binders
Sung-Ting Chuang, Péter Buchwald
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1084-1084
Open Access | Times Cited: 10
Viral Hijacking of Host RNA-Binding Proteins: Implications for Viral Replication and Pathogenesis
NGNOTOUOM NGNOKAM Tania Cyrielle, MAGNILACK Kuete Chanelle, Angyiba Serge Andigema
(2024)
Open Access | Times Cited: 1
Improvement of native structure-based peptides as efficient inhibitors of protein-protein interactions of SARS-CoV-2 spike protein and human ACE2
Norbert Odolczyk, Joanna Klim, Malgorzata Bialoskorska, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 5
Structure-based drug discovery to identify SARS-CoV2 spike protein–ACE2 interaction inhibitors
Ravi Kant, Rahul Kaushik, Madhu Chopra, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-19
Closed Access
In silico molecular screening of bioactive natural compounds of rosemary essential oil and extracts for pharmacological potentials against rhinoviruses
Dhananjay Singh, Nishu Mittal, Pooja Mittal, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Ethanol Inhalation as a Method to Denature the Spike Protein of SARS-CoV-2
Thomas J. Manning, Teighlor Livingston, C Persaud, et al.
Advances in experimental medicine and biology (2024), pp. 45-77
Closed Access
Small-molecule inhibitors of the CD40–CD40L costimulatory interaction are effective in pancreatic islet transplantation and prevention of type 1 diabetes models
Sung-Ting Chuang, Óscar Garnica, B.M. Watts, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
AI Promoted Virtual Screening, Structure-Based Hit Optimization, and Synthesis of Novel COVID-19 S-RBD Domain Inhibitors
Ioannis Gkekas, Sotirios Katsamakas, Stelios K. Mylonas, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 22, pp. 8562-8585
Open Access
New insights into protein–protein interaction modulators in drug discovery and therapeutic advance
Hossam Nada, Yongseok Choi, Sung-Do Kim, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access
Page 1

Scroll to top